Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities

NCT07004426 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT07004426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Completed
Start date
June 1, 2025
Completion date
July 15, 2025
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign renal neoplasm, renal carcinoma, renal cell carcinoma (kidney cancer)